Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

June 01, 1999; Volume 27,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Álvarez, A. I.

    1. You have access
      Presystemic Metabolism of Albendazole: Experimental Evidence of an Efflux Process of Albendazole Sulfoxide to Intestinal Lumen
      P. A. Redondo, A. I. Álvarez, J. L. Garcia, O. M. Larrodé, G. Merino and J. G. Prieto
      Drug Metabolism and Disposition June 1999, 27 (6) 736-740;
  2. Armstrong, Arthur P.

    1. You have access
      Mechanism-Based Inactivation of Rat Liver Cytochrome P-450 2B1 by 2-Methoxy-5-nitrobenzyl Bromide
      Arthur P. Armstrong and Paul F. Hollenberg
      Drug Metabolism and Disposition June 1999, 27 (6) 741-745;

B

  1. Blouin, Robert A.

    1. You have access
      Effect of Leptin on Cytochrome P-450, Conjugation, and Antioxidant Enzymes in the ob/ob Mouse
      Angela M. Watson, Samuel M. Poloyac, Georgette Howard and Robert A. Blouin
      Drug Metabolism and Disposition June 1999, 27 (6) 695-700;
  2. Boxenbaum, Harold

    1. You have access
      Estimation of K i in a Competitive Enzyme-Inhibition Model: Comparisons Among Three Methods of Data Analysis
      Tarundeep Kakkar, Harold Boxenbaum and Michael Mayersohn
      Drug Metabolism and Disposition June 1999, 27 (6) 756-762;
  3. Brouwer, Kenneth R.

    1. You have access
      Correlation of Biliary Excretion in Sandwich-Cultured Rat Hepatocytes and In Vivo in Rats
      Xingrong Liu, Jack P. Chism, Edward L. LeCluyse, Kenneth R. Brouwer and Kim L.R. Brouwer
      Drug Metabolism and Disposition June 1999, 27 (6) 637-644;
  4. Brouwer, Kim L.R.

    1. You have access
      Correlation of Biliary Excretion in Sandwich-Cultured Rat Hepatocytes and In Vivo in Rats
      Xingrong Liu, Jack P. Chism, Edward L. LeCluyse, Kenneth R. Brouwer and Kim L.R. Brouwer
      Drug Metabolism and Disposition June 1999, 27 (6) 637-644;

C

  1. Chism, Jack P.

    1. You have access
      Correlation of Biliary Excretion in Sandwich-Cultured Rat Hepatocytes and In Vivo in Rats
      Xingrong Liu, Jack P. Chism, Edward L. LeCluyse, Kenneth R. Brouwer and Kim L.R. Brouwer
      Drug Metabolism and Disposition June 1999, 27 (6) 637-644;
  2. Cho, Min Kyung

    1. You have access
      Molecular Basis for Hepatic Detoxifying Enzyme Induction by 2-(Allylthio)pyrazine in Rats in Comparison with Oltipraz: Effects on Prooxidant Production and DNA Degradation
      Sang Geon Kim, Min Kyung Cho, Sung Hee Choi, Hye Jung Kim, Mi Kyong Kwak and Nak Doo Kim
      Drug Metabolism and Disposition June 1999, 27 (6) 667-673;
  3. Choi, Sung Hee

    1. You have access
      Molecular Basis for Hepatic Detoxifying Enzyme Induction by 2-(Allylthio)pyrazine in Rats in Comparison with Oltipraz: Effects on Prooxidant Production and DNA Degradation
      Sang Geon Kim, Min Kyung Cho, Sung Hee Choi, Hye Jung Kim, Mi Kyong Kwak and Nak Doo Kim
      Drug Metabolism and Disposition June 1999, 27 (6) 667-673;
  4. Chu, Kai-Min

    1. You have access
      Cardiovascular Effect and Simultaneous Pharmacokinetic and Pharmacodynamic Modeling of Pimobendan in Healthy Normal Subjects
      Kai-Min Chu, Oliver Yoa-Pu Hu and Shyh-Ming Shieh
      Drug Metabolism and Disposition June 1999, 27 (6) 701-709;
  5. Crespi, Charles L.

    1. You have access
      Development of a Substrate-Activity Based Approach To Identify the Major Human Liver P-450 Catalysts of Cyclophosphamide and Ifosfamide Activation Based on cDNA-Expressed Activities and Liver Microsomal P-450 Profiles
      Partha Roy, Li J. Yu, Charles L. Crespi and David J. Waxman
      Drug Metabolism and Disposition June 1999, 27 (6) 655-666;

D

  1. Dehal, Shangara S.

    1. You have access
      Cytochrome P-450 3A and 2D6 Catalyze OrthoHydroxylation of 4-Hydroxytamoxifen and 3-Hydroxytamoxifen (Droloxifene) Yielding Tamoxifen Catechol: Involvement of Catechols in Covalent Binding to Hepatic Proteins
      Shangara S. Dehal and David Kupfer
      Drug Metabolism and Disposition June 1999, 27 (6) 681-688;

G

  1. Garcia, J. L.

    1. You have access
      Presystemic Metabolism of Albendazole: Experimental Evidence of an Efflux Process of Albendazole Sulfoxide to Intestinal Lumen
      P. A. Redondo, A. I. Álvarez, J. L. Garcia, O. M. Larrodé, G. Merino and J. G. Prieto
      Drug Metabolism and Disposition June 1999, 27 (6) 736-740;

H

  1. Hankins, Douglas C.

    1. You have access
      Lack of Single-Dose Disulfiram Effects on Cytochrome P-450 2C9, 2C19, 2D6, and 3A4 Activities: Evidence for Specificity Toward P-450 2E1
      Evan D. Kharasch, Douglas C. Hankins, Carole Jubert, Kenneth E. Thummel and Julie K. Taraday
      Drug Metabolism and Disposition June 1999, 27 (6) 717-723;
  2. Harvison, Peter J.

    1. You have access
      Comparative Disposition of the NephrotoxicantN-(3,5-Dichlorophenyl)Succinimide and the Non-Nephrotoxicant N-(3,5-Difluorophenyl)Succinimide in Fischer 344 Rats
      Caroline M. Henesey, Ginny L. Kellner-Weibel, Joan B. Tarloff and Peter J. Harvison
      Drug Metabolism and Disposition June 1999, 27 (6) 674-680;
  3. Hata, T.

    1. You have access
      The Disposition of 14C-Labeled Tacrolimus after Intravenous and Oral Administration in Healthy Human Subjects
      A. Möller, K. Iwasaki, A. Kawamura, Y. Teramura, T. Shiraga, T. Hata, A. Schäfer and N. A. Undre
      Drug Metabolism and Disposition June 1999, 27 (6) 633-636;
  4. Henesey, Caroline M.

    1. You have access
      Comparative Disposition of the NephrotoxicantN-(3,5-Dichlorophenyl)Succinimide and the Non-Nephrotoxicant N-(3,5-Difluorophenyl)Succinimide in Fischer 344 Rats
      Caroline M. Henesey, Ginny L. Kellner-Weibel, Joan B. Tarloff and Peter J. Harvison
      Drug Metabolism and Disposition June 1999, 27 (6) 674-680;
  5. Hollenberg, Paul F.

    1. You have access
      Mechanism-Based Inactivation of Rat Liver Cytochrome P-450 2B1 by 2-Methoxy-5-nitrobenzyl Bromide
      Arthur P. Armstrong and Paul F. Hollenberg
      Drug Metabolism and Disposition June 1999, 27 (6) 741-745;
  6. Howard, Georgette

    1. You have access
      Effect of Leptin on Cytochrome P-450, Conjugation, and Antioxidant Enzymes in the ob/ob Mouse
      Angela M. Watson, Samuel M. Poloyac, Georgette Howard and Robert A. Blouin
      Drug Metabolism and Disposition June 1999, 27 (6) 695-700;
  7. Hu, Oliver Yoa-Pu

    1. You have access
      Cardiovascular Effect and Simultaneous Pharmacokinetic and Pharmacodynamic Modeling of Pimobendan in Healthy Normal Subjects
      Kai-Min Chu, Oliver Yoa-Pu Hu and Shyh-Ming Shieh
      Drug Metabolism and Disposition June 1999, 27 (6) 701-709;

I

  1. Imura, Kaoru

    1. You have access
      Panipenem, A Carbapenem Antibiotic, Enhances the Glucuronidation of Intravenously Administered Valproic Acid in Rats
      Naotoshi Yamamura, Kaoru Imura, Hideo Naganuma and Kenji Nishimura
      Drug Metabolism and Disposition June 1999, 27 (6) 724-730;
  2. Iwasaki, K.

    1. You have access
      The Disposition of 14C-Labeled Tacrolimus after Intravenous and Oral Administration in Healthy Human Subjects
      A. Möller, K. Iwasaki, A. Kawamura, Y. Teramura, T. Shiraga, T. Hata, A. Schäfer and N. A. Undre
      Drug Metabolism and Disposition June 1999, 27 (6) 633-636;

J

  1. Jubert, Carole

    1. You have access
      Lack of Single-Dose Disulfiram Effects on Cytochrome P-450 2C9, 2C19, 2D6, and 3A4 Activities: Evidence for Specificity Toward P-450 2E1
      Evan D. Kharasch, Douglas C. Hankins, Carole Jubert, Kenneth E. Thummel and Julie K. Taraday
      Drug Metabolism and Disposition June 1999, 27 (6) 717-723;

K

  1. Kakkar, Tarundeep

    1. You have access
      Estimation of K i in a Competitive Enzyme-Inhibition Model: Comparisons Among Three Methods of Data Analysis
      Tarundeep Kakkar, Harold Boxenbaum and Michael Mayersohn
      Drug Metabolism and Disposition June 1999, 27 (6) 756-762;
  2. Kawai, Ryosei

    1. You have access
      Effect of PSC 833, a P-Glycoprotein Modulator, on the Disposition of Vincristine and Digoxin in Rats
      SaeHeum Song, Hiroshi Suzuki, Ryosei Kawai and Yuichi Sugiyama
      Drug Metabolism and Disposition June 1999, 27 (6) 689-694;
  3. Kawamura, A.

    1. You have access
      The Disposition of 14C-Labeled Tacrolimus after Intravenous and Oral Administration in Healthy Human Subjects
      A. Möller, K. Iwasaki, A. Kawamura, Y. Teramura, T. Shiraga, T. Hata, A. Schäfer and N. A. Undre
      Drug Metabolism and Disposition June 1999, 27 (6) 633-636;
  4. Kellner-Weibel, Ginny L.

    1. You have access
      Comparative Disposition of the NephrotoxicantN-(3,5-Dichlorophenyl)Succinimide and the Non-Nephrotoxicant N-(3,5-Difluorophenyl)Succinimide in Fischer 344 Rats
      Caroline M. Henesey, Ginny L. Kellner-Weibel, Joan B. Tarloff and Peter J. Harvison
      Drug Metabolism and Disposition June 1999, 27 (6) 674-680;
  5. Kharasch, Evan D.

    1. You have access
      Lack of Single-Dose Disulfiram Effects on Cytochrome P-450 2C9, 2C19, 2D6, and 3A4 Activities: Evidence for Specificity Toward P-450 2E1
      Evan D. Kharasch, Douglas C. Hankins, Carole Jubert, Kenneth E. Thummel and Julie K. Taraday
      Drug Metabolism and Disposition June 1999, 27 (6) 717-723;
  6. Kim, Hye Jung

    1. You have access
      Molecular Basis for Hepatic Detoxifying Enzyme Induction by 2-(Allylthio)pyrazine in Rats in Comparison with Oltipraz: Effects on Prooxidant Production and DNA Degradation
      Sang Geon Kim, Min Kyung Cho, Sung Hee Choi, Hye Jung Kim, Mi Kyong Kwak and Nak Doo Kim
      Drug Metabolism and Disposition June 1999, 27 (6) 667-673;
  7. Kim, Nak Doo

    1. You have access
      Molecular Basis for Hepatic Detoxifying Enzyme Induction by 2-(Allylthio)pyrazine in Rats in Comparison with Oltipraz: Effects on Prooxidant Production and DNA Degradation
      Sang Geon Kim, Min Kyung Cho, Sung Hee Choi, Hye Jung Kim, Mi Kyong Kwak and Nak Doo Kim
      Drug Metabolism and Disposition June 1999, 27 (6) 667-673;
  8. Kim, Sang Geon

    1. You have access
      Molecular Basis for Hepatic Detoxifying Enzyme Induction by 2-(Allylthio)pyrazine in Rats in Comparison with Oltipraz: Effects on Prooxidant Production and DNA Degradation
      Sang Geon Kim, Min Kyung Cho, Sung Hee Choi, Hye Jung Kim, Mi Kyong Kwak and Nak Doo Kim
      Drug Metabolism and Disposition June 1999, 27 (6) 667-673;
  9. Kim, So H.

    1. You have access
      Pharmacokinetic Changes of a New Carbapenem, DA-1131, after Intravenous Administration to Spontaneously Hypertensive Rats and Deoxycorticosterone Acetate-Salt-Induced Hypertensive Rats
      So H. Kim, Won B. Kim and Myung G. Lee
      Drug Metabolism and Disposition June 1999, 27 (6) 710-716;
  10. Kim, Won B.

    1. You have access
      Pharmacokinetic Changes of a New Carbapenem, DA-1131, after Intravenous Administration to Spontaneously Hypertensive Rats and Deoxycorticosterone Acetate-Salt-Induced Hypertensive Rats
      So H. Kim, Won B. Kim and Myung G. Lee
      Drug Metabolism and Disposition June 1999, 27 (6) 710-716;
  11. Kobayashi, Shinichi

    1. You have access
      Dihydropyrimidine Dehydrogenase Activity and Fluorouracil Pharmacokinetics with Liver Damage Induced by Bile Duct Ligation in Rats
      Tomonori Tateishi, Minoru Watanabe, Hironori Nakura, Masami Tanaka, Toshio Kumai, Shigeko Fujimoto Sakata, Nanaya Tamaki, Kenichiro Ogura, Takahito Nishiyama, Tadashi Watabe and Shinichi Kobayashi
      Drug Metabolism and Disposition June 1999, 27 (6) 651-654;
  12. Kumai, Toshio

    1. You have access
      Dihydropyrimidine Dehydrogenase Activity and Fluorouracil Pharmacokinetics with Liver Damage Induced by Bile Duct Ligation in Rats
      Tomonori Tateishi, Minoru Watanabe, Hironori Nakura, Masami Tanaka, Toshio Kumai, Shigeko Fujimoto Sakata, Nanaya Tamaki, Kenichiro Ogura, Takahito Nishiyama, Tadashi Watabe and Shinichi Kobayashi
      Drug Metabolism and Disposition June 1999, 27 (6) 651-654;
  13. Kupfer, David

    1. You have access
      Cytochrome P-450 3A and 2D6 Catalyze OrthoHydroxylation of 4-Hydroxytamoxifen and 3-Hydroxytamoxifen (Droloxifene) Yielding Tamoxifen Catechol: Involvement of Catechols in Covalent Binding to Hepatic Proteins
      Shangara S. Dehal and David Kupfer
      Drug Metabolism and Disposition June 1999, 27 (6) 681-688;
  14. Kwak, Mi Kyong

    1. You have access
      Molecular Basis for Hepatic Detoxifying Enzyme Induction by 2-(Allylthio)pyrazine in Rats in Comparison with Oltipraz: Effects on Prooxidant Production and DNA Degradation
      Sang Geon Kim, Min Kyung Cho, Sung Hee Choi, Hye Jung Kim, Mi Kyong Kwak and Nak Doo Kim
      Drug Metabolism and Disposition June 1999, 27 (6) 667-673;

L

  1. Larrodé, O. M.

    1. You have access
      Presystemic Metabolism of Albendazole: Experimental Evidence of an Efflux Process of Albendazole Sulfoxide to Intestinal Lumen
      P. A. Redondo, A. I. Álvarez, J. L. Garcia, O. M. Larrodé, G. Merino and J. G. Prieto
      Drug Metabolism and Disposition June 1999, 27 (6) 736-740;
  2. LeCluyse, Edward L.

    1. You have access
      Correlation of Biliary Excretion in Sandwich-Cultured Rat Hepatocytes and In Vivo in Rats
      Xingrong Liu, Jack P. Chism, Edward L. LeCluyse, Kenneth R. Brouwer and Kim L.R. Brouwer
      Drug Metabolism and Disposition June 1999, 27 (6) 637-644;
  3. Lee, Myung G.

    1. You have access
      Pharmacokinetic Changes of a New Carbapenem, DA-1131, after Intravenous Administration to Spontaneously Hypertensive Rats and Deoxycorticosterone Acetate-Salt-Induced Hypertensive Rats
      So H. Kim, Won B. Kim and Myung G. Lee
      Drug Metabolism and Disposition June 1999, 27 (6) 710-716;
  4. Liu, Xingrong

    1. You have access
      Correlation of Biliary Excretion in Sandwich-Cultured Rat Hepatocytes and In Vivo in Rats
      Xingrong Liu, Jack P. Chism, Edward L. LeCluyse, Kenneth R. Brouwer and Kim L.R. Brouwer
      Drug Metabolism and Disposition June 1999, 27 (6) 637-644;

M

  1. Mayersohn, Michael

    1. You have access
      Estimation of K i in a Competitive Enzyme-Inhibition Model: Comparisons Among Three Methods of Data Analysis
      Tarundeep Kakkar, Harold Boxenbaum and Michael Mayersohn
      Drug Metabolism and Disposition June 1999, 27 (6) 756-762;
  2. Merino, G.

    1. You have access
      Presystemic Metabolism of Albendazole: Experimental Evidence of an Efflux Process of Albendazole Sulfoxide to Intestinal Lumen
      P. A. Redondo, A. I. Álvarez, J. L. Garcia, O. M. Larrodé, G. Merino and J. G. Prieto
      Drug Metabolism and Disposition June 1999, 27 (6) 736-740;
  3. Möller, A.

    1. You have access
      The Disposition of 14C-Labeled Tacrolimus after Intravenous and Oral Administration in Healthy Human Subjects
      A. Möller, K. Iwasaki, A. Kawamura, Y. Teramura, T. Shiraga, T. Hata, A. Schäfer and N. A. Undre
      Drug Metabolism and Disposition June 1999, 27 (6) 633-636;

N

  1. Naganuma, Hideo

    1. You have access
      Panipenem, A Carbapenem Antibiotic, Enhances the Glucuronidation of Intravenously Administered Valproic Acid in Rats
      Naotoshi Yamamura, Kaoru Imura, Hideo Naganuma and Kenji Nishimura
      Drug Metabolism and Disposition June 1999, 27 (6) 724-730;
  2. Nakura, Hironori

    1. You have access
      Dihydropyrimidine Dehydrogenase Activity and Fluorouracil Pharmacokinetics with Liver Damage Induced by Bile Duct Ligation in Rats
      Tomonori Tateishi, Minoru Watanabe, Hironori Nakura, Masami Tanaka, Toshio Kumai, Shigeko Fujimoto Sakata, Nanaya Tamaki, Kenichiro Ogura, Takahito Nishiyama, Tadashi Watabe and Shinichi Kobayashi
      Drug Metabolism and Disposition June 1999, 27 (6) 651-654;
  3. Nishimura, Kenji

    1. You have access
      Panipenem, A Carbapenem Antibiotic, Enhances the Glucuronidation of Intravenously Administered Valproic Acid in Rats
      Naotoshi Yamamura, Kaoru Imura, Hideo Naganuma and Kenji Nishimura
      Drug Metabolism and Disposition June 1999, 27 (6) 724-730;
  4. Nishiyama, Takahito

    1. You have access
      Dihydropyrimidine Dehydrogenase Activity and Fluorouracil Pharmacokinetics with Liver Damage Induced by Bile Duct Ligation in Rats
      Tomonori Tateishi, Minoru Watanabe, Hironori Nakura, Masami Tanaka, Toshio Kumai, Shigeko Fujimoto Sakata, Nanaya Tamaki, Kenichiro Ogura, Takahito Nishiyama, Tadashi Watabe and Shinichi Kobayashi
      Drug Metabolism and Disposition June 1999, 27 (6) 651-654;

O

  1. Ogura, Kenichiro

    1. You have access
      Dihydropyrimidine Dehydrogenase Activity and Fluorouracil Pharmacokinetics with Liver Damage Induced by Bile Duct Ligation in Rats
      Tomonori Tateishi, Minoru Watanabe, Hironori Nakura, Masami Tanaka, Toshio Kumai, Shigeko Fujimoto Sakata, Nanaya Tamaki, Kenichiro Ogura, Takahito Nishiyama, Tadashi Watabe and Shinichi Kobayashi
      Drug Metabolism and Disposition June 1999, 27 (6) 651-654;

P

  1. Pang, K. Sandy

    1. You have access
      The Multiple Indicator-Dilution Method for the Study of Enzyme Heterogeneity in Liver: Theoretical Basis
      Andreas J. Schwab and K. Sandy Pang
      Drug Metabolism and Disposition June 1999, 27 (6) 746-755;
  2. Perel, James M.

    1. You have access
      Comparative Pharmacokinetics and Tissue Distribution of the d-Enantiomers of Para-Substituted Methylphenidate Analogs
      Dung L. Thai, Linda N. Yurasits, George R. Rudolph and James M. Perel
      Drug Metabolism and Disposition June 1999, 27 (6) 645-650;
  3. Poloyac, Samuel M.

    1. You have access
      Effect of Leptin on Cytochrome P-450, Conjugation, and Antioxidant Enzymes in the ob/ob Mouse
      Angela M. Watson, Samuel M. Poloyac, Georgette Howard and Robert A. Blouin
      Drug Metabolism and Disposition June 1999, 27 (6) 695-700;
  4. Prieto, J. G.

    1. You have access
      Presystemic Metabolism of Albendazole: Experimental Evidence of an Efflux Process of Albendazole Sulfoxide to Intestinal Lumen
      P. A. Redondo, A. I. Álvarez, J. L. Garcia, O. M. Larrodé, G. Merino and J. G. Prieto
      Drug Metabolism and Disposition June 1999, 27 (6) 736-740;

R

  1. Redondo, P. A.

    1. You have access
      Presystemic Metabolism of Albendazole: Experimental Evidence of an Efflux Process of Albendazole Sulfoxide to Intestinal Lumen
      P. A. Redondo, A. I. Álvarez, J. L. Garcia, O. M. Larrodé, G. Merino and J. G. Prieto
      Drug Metabolism and Disposition June 1999, 27 (6) 736-740;
  2. Roy, Partha

    1. You have access
      Development of a Substrate-Activity Based Approach To Identify the Major Human Liver P-450 Catalysts of Cyclophosphamide and Ifosfamide Activation Based on cDNA-Expressed Activities and Liver Microsomal P-450 Profiles
      Partha Roy, Li J. Yu, Charles L. Crespi and David J. Waxman
      Drug Metabolism and Disposition June 1999, 27 (6) 655-666;
  3. Rudolph, George R.

    1. You have access
      Comparative Pharmacokinetics and Tissue Distribution of the d-Enantiomers of Para-Substituted Methylphenidate Analogs
      Dung L. Thai, Linda N. Yurasits, George R. Rudolph and James M. Perel
      Drug Metabolism and Disposition June 1999, 27 (6) 645-650;
  4. Ruth, James A.

    1. You have access
      Deposition of [3H]Cocaine, [3H]Nicotine, and [3H]Flunitrazepam in Mouse Hair Melanosomes after Systemic Administration
      Peter R. Stout and James A. Ruth
      Drug Metabolism and Disposition June 1999, 27 (6) 731-735;

S

  1. Sakata, Shigeko Fujimoto

    1. You have access
      Dihydropyrimidine Dehydrogenase Activity and Fluorouracil Pharmacokinetics with Liver Damage Induced by Bile Duct Ligation in Rats
      Tomonori Tateishi, Minoru Watanabe, Hironori Nakura, Masami Tanaka, Toshio Kumai, Shigeko Fujimoto Sakata, Nanaya Tamaki, Kenichiro Ogura, Takahito Nishiyama, Tadashi Watabe and Shinichi Kobayashi
      Drug Metabolism and Disposition June 1999, 27 (6) 651-654;
  2. Schäfer, A.

    1. You have access
      The Disposition of 14C-Labeled Tacrolimus after Intravenous and Oral Administration in Healthy Human Subjects
      A. Möller, K. Iwasaki, A. Kawamura, Y. Teramura, T. Shiraga, T. Hata, A. Schäfer and N. A. Undre
      Drug Metabolism and Disposition June 1999, 27 (6) 633-636;
  3. Schwab, Andreas J.

    1. You have access
      The Multiple Indicator-Dilution Method for the Study of Enzyme Heterogeneity in Liver: Theoretical Basis
      Andreas J. Schwab and K. Sandy Pang
      Drug Metabolism and Disposition June 1999, 27 (6) 746-755;
  4. Shieh, Shyh-Ming

    1. You have access
      Cardiovascular Effect and Simultaneous Pharmacokinetic and Pharmacodynamic Modeling of Pimobendan in Healthy Normal Subjects
      Kai-Min Chu, Oliver Yoa-Pu Hu and Shyh-Ming Shieh
      Drug Metabolism and Disposition June 1999, 27 (6) 701-709;
  5. Shiraga, T.

    1. You have access
      The Disposition of 14C-Labeled Tacrolimus after Intravenous and Oral Administration in Healthy Human Subjects
      A. Möller, K. Iwasaki, A. Kawamura, Y. Teramura, T. Shiraga, T. Hata, A. Schäfer and N. A. Undre
      Drug Metabolism and Disposition June 1999, 27 (6) 633-636;
  6. Song, SaeHeum

    1. You have access
      Effect of PSC 833, a P-Glycoprotein Modulator, on the Disposition of Vincristine and Digoxin in Rats
      SaeHeum Song, Hiroshi Suzuki, Ryosei Kawai and Yuichi Sugiyama
      Drug Metabolism and Disposition June 1999, 27 (6) 689-694;
  7. Stout, Peter R.

    1. You have access
      Deposition of [3H]Cocaine, [3H]Nicotine, and [3H]Flunitrazepam in Mouse Hair Melanosomes after Systemic Administration
      Peter R. Stout and James A. Ruth
      Drug Metabolism and Disposition June 1999, 27 (6) 731-735;
  8. Sugiyama, Yuichi

    1. You have access
      Effect of PSC 833, a P-Glycoprotein Modulator, on the Disposition of Vincristine and Digoxin in Rats
      SaeHeum Song, Hiroshi Suzuki, Ryosei Kawai and Yuichi Sugiyama
      Drug Metabolism and Disposition June 1999, 27 (6) 689-694;
  9. Suzuki, Hiroshi

    1. You have access
      Effect of PSC 833, a P-Glycoprotein Modulator, on the Disposition of Vincristine and Digoxin in Rats
      SaeHeum Song, Hiroshi Suzuki, Ryosei Kawai and Yuichi Sugiyama
      Drug Metabolism and Disposition June 1999, 27 (6) 689-694;

T

  1. Tamaki, Nanaya

    1. You have access
      Dihydropyrimidine Dehydrogenase Activity and Fluorouracil Pharmacokinetics with Liver Damage Induced by Bile Duct Ligation in Rats
      Tomonori Tateishi, Minoru Watanabe, Hironori Nakura, Masami Tanaka, Toshio Kumai, Shigeko Fujimoto Sakata, Nanaya Tamaki, Kenichiro Ogura, Takahito Nishiyama, Tadashi Watabe and Shinichi Kobayashi
      Drug Metabolism and Disposition June 1999, 27 (6) 651-654;
  2. Tanaka, Masami

    1. You have access
      Dihydropyrimidine Dehydrogenase Activity and Fluorouracil Pharmacokinetics with Liver Damage Induced by Bile Duct Ligation in Rats
      Tomonori Tateishi, Minoru Watanabe, Hironori Nakura, Masami Tanaka, Toshio Kumai, Shigeko Fujimoto Sakata, Nanaya Tamaki, Kenichiro Ogura, Takahito Nishiyama, Tadashi Watabe and Shinichi Kobayashi
      Drug Metabolism and Disposition June 1999, 27 (6) 651-654;
  3. Taraday, Julie K.

    1. You have access
      Lack of Single-Dose Disulfiram Effects on Cytochrome P-450 2C9, 2C19, 2D6, and 3A4 Activities: Evidence for Specificity Toward P-450 2E1
      Evan D. Kharasch, Douglas C. Hankins, Carole Jubert, Kenneth E. Thummel and Julie K. Taraday
      Drug Metabolism and Disposition June 1999, 27 (6) 717-723;
  4. Tarloff, Joan B.

    1. You have access
      Comparative Disposition of the NephrotoxicantN-(3,5-Dichlorophenyl)Succinimide and the Non-Nephrotoxicant N-(3,5-Difluorophenyl)Succinimide in Fischer 344 Rats
      Caroline M. Henesey, Ginny L. Kellner-Weibel, Joan B. Tarloff and Peter J. Harvison
      Drug Metabolism and Disposition June 1999, 27 (6) 674-680;
  5. Tateishi, Tomonori

    1. You have access
      Dihydropyrimidine Dehydrogenase Activity and Fluorouracil Pharmacokinetics with Liver Damage Induced by Bile Duct Ligation in Rats
      Tomonori Tateishi, Minoru Watanabe, Hironori Nakura, Masami Tanaka, Toshio Kumai, Shigeko Fujimoto Sakata, Nanaya Tamaki, Kenichiro Ogura, Takahito Nishiyama, Tadashi Watabe and Shinichi Kobayashi
      Drug Metabolism and Disposition June 1999, 27 (6) 651-654;
  6. Teramura, Y.

    1. You have access
      The Disposition of 14C-Labeled Tacrolimus after Intravenous and Oral Administration in Healthy Human Subjects
      A. Möller, K. Iwasaki, A. Kawamura, Y. Teramura, T. Shiraga, T. Hata, A. Schäfer and N. A. Undre
      Drug Metabolism and Disposition June 1999, 27 (6) 633-636;
  7. Thai, Dung L.

    1. You have access
      Comparative Pharmacokinetics and Tissue Distribution of the d-Enantiomers of Para-Substituted Methylphenidate Analogs
      Dung L. Thai, Linda N. Yurasits, George R. Rudolph and James M. Perel
      Drug Metabolism and Disposition June 1999, 27 (6) 645-650;
  8. Thummel, Kenneth E.

    1. You have access
      Lack of Single-Dose Disulfiram Effects on Cytochrome P-450 2C9, 2C19, 2D6, and 3A4 Activities: Evidence for Specificity Toward P-450 2E1
      Evan D. Kharasch, Douglas C. Hankins, Carole Jubert, Kenneth E. Thummel and Julie K. Taraday
      Drug Metabolism and Disposition June 1999, 27 (6) 717-723;

U

  1. Undre, N. A.

    1. You have access
      The Disposition of 14C-Labeled Tacrolimus after Intravenous and Oral Administration in Healthy Human Subjects
      A. Möller, K. Iwasaki, A. Kawamura, Y. Teramura, T. Shiraga, T. Hata, A. Schäfer and N. A. Undre
      Drug Metabolism and Disposition June 1999, 27 (6) 633-636;

W

  1. Watabe, Tadashi

    1. You have access
      Dihydropyrimidine Dehydrogenase Activity and Fluorouracil Pharmacokinetics with Liver Damage Induced by Bile Duct Ligation in Rats
      Tomonori Tateishi, Minoru Watanabe, Hironori Nakura, Masami Tanaka, Toshio Kumai, Shigeko Fujimoto Sakata, Nanaya Tamaki, Kenichiro Ogura, Takahito Nishiyama, Tadashi Watabe and Shinichi Kobayashi
      Drug Metabolism and Disposition June 1999, 27 (6) 651-654;
  2. Watanabe, Minoru

    1. You have access
      Dihydropyrimidine Dehydrogenase Activity and Fluorouracil Pharmacokinetics with Liver Damage Induced by Bile Duct Ligation in Rats
      Tomonori Tateishi, Minoru Watanabe, Hironori Nakura, Masami Tanaka, Toshio Kumai, Shigeko Fujimoto Sakata, Nanaya Tamaki, Kenichiro Ogura, Takahito Nishiyama, Tadashi Watabe and Shinichi Kobayashi
      Drug Metabolism and Disposition June 1999, 27 (6) 651-654;
  3. Watson, Angela M.

    1. You have access
      Effect of Leptin on Cytochrome P-450, Conjugation, and Antioxidant Enzymes in the ob/ob Mouse
      Angela M. Watson, Samuel M. Poloyac, Georgette Howard and Robert A. Blouin
      Drug Metabolism and Disposition June 1999, 27 (6) 695-700;
  4. Waxman, David J.

    1. You have access
      Development of a Substrate-Activity Based Approach To Identify the Major Human Liver P-450 Catalysts of Cyclophosphamide and Ifosfamide Activation Based on cDNA-Expressed Activities and Liver Microsomal P-450 Profiles
      Partha Roy, Li J. Yu, Charles L. Crespi and David J. Waxman
      Drug Metabolism and Disposition June 1999, 27 (6) 655-666;

Y

  1. Yamamura, Naotoshi

    1. You have access
      Panipenem, A Carbapenem Antibiotic, Enhances the Glucuronidation of Intravenously Administered Valproic Acid in Rats
      Naotoshi Yamamura, Kaoru Imura, Hideo Naganuma and Kenji Nishimura
      Drug Metabolism and Disposition June 1999, 27 (6) 724-730;
  2. Yu, Li J.

    1. You have access
      Development of a Substrate-Activity Based Approach To Identify the Major Human Liver P-450 Catalysts of Cyclophosphamide and Ifosfamide Activation Based on cDNA-Expressed Activities and Liver Microsomal P-450 Profiles
      Partha Roy, Li J. Yu, Charles L. Crespi and David J. Waxman
      Drug Metabolism and Disposition June 1999, 27 (6) 655-666;
  3. Yurasits, Linda N.

    1. You have access
      Comparative Pharmacokinetics and Tissue Distribution of the d-Enantiomers of Para-Substituted Methylphenidate Analogs
      Dung L. Thai, Linda N. Yurasits, George R. Rudolph and James M. Perel
      Drug Metabolism and Disposition June 1999, 27 (6) 645-650;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 27 (6)
Drug Metabolism and Disposition
Vol. 27, Issue 6
1 Jun 1999
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics